We are live on ! Find out more
GDL

GDL Fund

41 hedge funds and large institutions have $87.1M invested in GDL Fund in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

8% more funds holding

Funds holding: 3841 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.03% less ownership

Funds ownership: 38.29%38.26% (-0.03%)

2% less capital invested

Capital invested by funds: $88.9M → $87.1M (-$1.79M)

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
14
Reduced
10
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GDL Hedge Fund Activity: Q2 2014 in Review

41 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in GDL Fund (GDL) for Q2 2014, worth a combined $87.1M — down 2% from $88.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GDL positions and 3 closed out — a net gain of 3 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Rivernorth Capital Management, adding an estimated $1.02M. The largest seller was Lazard Asset Management, cutting an estimated $5.75M.

  • 41 institutional investors held GDL Fund (GDL) as of Q2 2014, up from 38 in Q1 2014.
  • Funds reported $87.1M of GDL Fund stock for Q2 2014, down 2% quarter-over-quarter.
  • 6 funds opened new GDL Fund positions in Q2 2014 and 3 closed out, a net change of +3 holders.
  • The largest GDL Fund buyer in Q2 2014 was Rivernorth Capital Management, an estimated $1.02M added.
  • The largest GDL Fund seller in Q2 2014 was Lazard Asset Management, an estimated $5.75M sold.

Based on aggregated 13F filings for Q2 2014.